Particularly attractive are innovators like biopharma developer InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), which has a compelling biosynthesis technology that will allow the company to manufacture bio-identical cannabinoids of every naturally occurring ones in-house, without the need for plant feedstock.
Articles
Cannabis Stock Bull Market Primed for Even More Growth as Major Markets Legalize
Backed by mounting scientific data on the curative effects of CBDs, specialty biotech companies like InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) have the opportunity to capitalize on the explosive growth expected in the cannabis-derived pharmaceutical market.
Global Payout, Inc. (GOHE) Announces Development of New Subsidiary for Blockchain Technology Applications in the Trillion Dollar Logistics Industry
Global Payout, Inc. (OTC: GOHE) announced plans to launch a new subsidiary early next year that will focus on supplying chain finance solutions for the logistics industry.
SinglePoint, Inc. (SING) Formalizes LOI for JV Agreement with Smart Cannabis Corp. (SCNA); Completes Corporate Audit
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has formalized a letter of intent signed earlier this month related to its entry into a multifaceted joint venture and co-marketing agreement with Smart Cannabis Corp. (OTC: SCNA).
Rapidly Growing Cannabis Market Has Massive Impact on Multiple Industry Sectors
As the cannabis industry continues its rapid growth, its overall impact on other industry sectors is also dramatically increasing.
Biotech Market Banking on Big Cannabis Returns
Backed by mounting scientific data on the curative effects of CBDs, specialty biotech companies like InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) have the opportunity to capitalize on the explosive growth expected in the cannabis-derived pharmaceutical market.
Canadians are already spending almost as much on marijuana as wine
The $6.2 billion in weed Canadians consume a year is about two-thirds the $9.2 billion beer market and close to wine’s $7 billion tally
Despite Cryptocurrency Skepticisms, Standout Players Continue to Ride the Meteoric Rise of Bitcoin
Cryptocurrencies like bitcoin are proving especially valuable as a solution for high-risk industries like cannabis, which remains largely unbanked in the United States due to marijuana’s continued status as a Schedule 1 drug under the Controlled Substances Act.
India Globalization Capital, Inc. (NYSE: IGC) Adjourns Voting for Proposals Three and Four from Annual Meeting of Shareholders
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has adjourned the voting for proposals three and four from its notice of annual meeting of shareholders, dated October 5, 2017.
SinglePoint’s (SING) Bitcoin Payment App Highlighted in CNBC Article – Offers Alternative to Cash-only Cannabis Industry
Publicly traded holding company SinglePoint, Inc. (OTC: SING) and its innovative SingleSeed app – designed to allow cannabis dispensaries and customers to exchange funds using debit and credit cards via the vehicle of bitcoin – is singled out in a CNBC article highlighting the industry’s ongoing need for an alternative banking solution (http://cnw.fm/3bA32).
Aurora Cannabis to Make Strategic Investment in Micron Waste Technologies
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Micron Waste Technologies Inc. ("Micron") (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), today announced that the companies have signed a non-binding term sheet for Aurora to make a strategic investment in Micron, and for both companies to collaborate on the optimization of Micron's technology for the treatment of organic waste generated in the cultivation and production of cannabis products..
Medical Cannabis Payment Solutions (REFG) is at the Forefront of the Multi-Billion Legal Cannabis Market
Within the current multi-billion dollar and rapidly-growing industry (New Frontier Data projects U.S. medical and recreational marijuana sales will reach $24.5 billion by 2025) (http://cnw.fm/A0lmE), REFG is a frontrunner in the booming market that is vying to match growing demand with full spectrum solutions.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Added to Horizons Marijuana Life Sciences Index ETF
Horizons ETFs Management (Canada) Inc. recently announced completion of its quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ”).
Biotech Market Banking on Big Cannabis Returns
Relatively insulated from economic cycles, the innovation of today’s biotech companies puts them in a position to potentially deliver outsized returns regardless of overall conditions.
Horizons ETFs Expands the Portfolio of its Marijuana-Focused ETF, Adding InMed
InMed's addition to Canada’s Cannabis ETF Could Be Signalling the Start of a Big New Investing Theme = Biotechs.
